Pacira Pharmaceuticals buy HC Wainwright
Start price
08.05.24
/
50%
€26.80
Target price
08.05.25
€53.04
Performance (%)
6.72%
Price
17.05.24
€28.00
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright shows slight gains of 6.72%. This prediction currently runs until 08.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | 3.704% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
9.16%
17.05.24
17.05.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
0.70%
17.05.24
17.05.24